Novartis AG (BSP:N1VS34)
R$ 64.54 4.05 (6.7%) Market Cap: 1.29 Tn Enterprise Value: 1.39 Tn PE Ratio: 13.36 PB Ratio: 5.41 GF Score: 77/100

Q3 2022 Novartis AG Earnings Presentation Transcript

Oct 25, 2022 / 12:00PM GMT
Release Date Price: R$40.36

Oct 25, 2022 / 12:00PM GMT
Presentation
Oct 25, 2022 / 12:00PM GMT

=====================
Corporate Participants
=====================
* Harry Kirsch
Novartis AG - CFO
* Samir Shah
Novartis AG - Global Head of IR
* Vasant Narasimhan
Novartis AG - CEO

=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emily Field
Barclays Bank PLC, Research Division - Research Analyst
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Florent Cespedes
Societe Generale Cross Asset Research - Senior Equity Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* Kerry Ann Holford
Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
* Keyur Parekh
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Mark Douglas Purcell

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot